Results 311 to 320 of about 3,353,866 (404)

ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology

open access: yesInternational Journal of Cancer, Volume 157, Issue 9, Page 1939-1947, 1 November 2025.
What's new? This study introduces ADAR1 mRNA quantification as a promising biomarker for improving high‐grade squamous intraepithelial lesion (HSIL) prediction in HIV‐positive individuals with abnormal anal cytology. With 92% specificity, it reduces unnecessary high‐resolution anoscopies (HRA) by 77%, offering a more efficient and targeted screening ...
Melissa Bello‐Perez   +15 more
wiley   +1 more source

Circumcision of HIV-infected men: effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda.

open access: yesJournal of Infectious Diseases, 2010
D. Serwadda   +18 more
semanticscholar   +1 more source

Elevating and empowering reproductive futures: Pediatric and adolescent gynecology's specialized care across the globe

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 528-537, November 2025.
Abstract Pediatric and adolescent gynecology (PAG) is an expanding subspecialty of obstetrics and gynecology that addresses the reproductive health needs of girls and young women worldwide. In regions with limited subspecialist healthcare providers, general obstetricians, gynecologists, and nurse‐midwives, frontline healthcare providers provide ...
Nichole A. Tyson   +6 more
wiley   +1 more source

Human Papillomavirus Infections and the Role Played by Cervical and Cervico-Vaginal Microbiota-Evidence from Next-Generation Sequencing Studies. [PDF]

open access: yesCancers (Basel)
Głowienka-Stodolak M   +8 more
europepmc   +1 more source

Human Papillomavirus Infection in Danish Female Sex Workers

open access: bronze, 2000
Susanne K. Kjær   +5 more
openalex   +1 more source

FIGO position statement on the effectiveness and safety of the HPV vaccine

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue 2, Page 545-549, November 2025.
Abstract Cervical cancer, which is primarily caused by persistent infection with oncogenic high‐risk human papillomavirus (hrHPV) types, remains a substantial health problem with the highest incidence and mortality rates in low‐ and middle‐income countries (LMICs).
Anna Marshall   +5 more
wiley   +1 more source

Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda. [PDF]

open access: yesBMC Cancer
Nakigozi H   +14 more
europepmc   +1 more source

Noncanonical Pathways of Proteasome Inhibition in HPV‐Negative Head & Neck Cancer

open access: yesMolecular Carcinogenesis, Volume 64, Issue 11, Page 1838-1850, November 2025.
Conceptual illustration of the differential effect of CFZ on HPV negative and positive HNSCC. ABSTRACT Carfilzomib, a second‐generation proteasome inhibitor approved for the treatment of multiple myeloma, is a highly potent and selective inhibitor of the CT‐L activity of the i20S proteasome.
Hye‐Yeon Lee   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy